Mesalamine Suspension
Product Images NDC 70954-301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 70954-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Bottle)

Label (Bottle)
This text provides information about a medication containing mesalamine in a suspension form for rectal administration. Each disposable unit-dose contains 4 grams of mesalamine along with other ingredients like carbomer 974P, edetate, disodium, potassium acetate, and xanthan gum. It is recommended to shake well before use and store between 20°C to 25°C (68°F to 77°F). The usual dose is one unit-dose daily before retiring for the night. The product is for rectal use only and should be kept out of reach of children. See the package insert for complete information.*
FDA Label Image

Carton (Carton)

Carton (Carton)
This text is not readable.*
FDA Label Image

Fig-a (Fig A)

FDA Label Image

Fig-b (Fig B)

Fig-b (Fig B)
This text mentions an Applicator Tip and Nozzle. These items are commonly used in various applications such as in cosmetics, adhesives, paints, or other liquids that require precision dispensing. The applicator tip helps control the flow of the substance, while the nozzle is used to direct the substance to a specific area. Both components are essential for accurate and efficient dispensing of liquids.*
FDA Label Image

Fig-c (Fig C)

FDA Label Image

Fig-d (Fig D)

FDA Label Image

Fig-e (Fig E)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.